Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Biohaven Pharmaceutical Holding Company Ltd
EPS (Diluted)
Biohaven Pharmaceutical Holding Company Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
|
EPS (Diluted)
-$5
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$13
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$33
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
See Also
What is Biohaven Pharmaceutical Holding Company Ltd's EPS (Diluted)?
EPS (Diluted)
-5.7
USD
Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's EPS (Diluted) amounts to -5.7 USD.
What is Biohaven Pharmaceutical Holding Company Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-46%
Over the last year, the EPS (Diluted) growth was 31%. The average annual EPS (Diluted) growth rates for Biohaven Pharmaceutical Holding Company Ltd have been -46% over the past three years .